Kahn Brothers Group Inc. purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 218,182 shares of the company’s stock, valued at approximately $28,036,000. Merck KGaA makes up 0.1% of Kahn Brothers Group Inc.’s holdings, making the stock its 19th largest holding. Kahn Brothers Group Inc. owned 0.17% of Merck KGaA at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in MKGAF. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA during the second quarter valued at $27,000. Solstein Capital LLC purchased a new stake in Merck KGaA during the 2nd quarter worth about $33,000. Delos Wealth Advisors LLC purchased a new stake in Merck KGaA during the 2nd quarter worth about $33,000. Finally, Burk Holdings LLC acquired a new position in Merck KGaA in the 2nd quarter valued at about $39,000. 0.10% of the stock is owned by institutional investors and hedge funds.
Merck KGaA Price Performance
OTCMKTS:MKGAF opened at $158.15 on Friday. The firm has a market cap of $20.44 billion, a price-to-earnings ratio of 24.14 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company’s 50-day moving average is $163.21 and its two-hundred day moving average is $148.95. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
